nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—CYP2B6—malignant glioma	0.51	1	CbGaD
Nicotine—CYP1A2—Carmustine—malignant glioma	0.0483	0.569	CbGbCtD
Nicotine—CYP3A4—Temozolomide—malignant glioma	0.0365	0.43	CbGbCtD
Nicotine—CHRNB3—pons—malignant glioma	0.0149	0.103	CbGeAlD
Nicotine—CHAT—cerebellar cortex—malignant glioma	0.0146	0.101	CbGeAlD
Nicotine—CHAT—pons—malignant glioma	0.0103	0.0712	CbGeAlD
Nicotine—CHAT—telencephalic ventricle—malignant glioma	0.00847	0.0586	CbGeAlD
Nicotine—CHRNA9—embryo—malignant glioma	0.00545	0.0377	CbGeAlD
Nicotine—CHRNA4—telencephalic ventricle—malignant glioma	0.00366	0.0253	CbGeAlD
Nicotine—CHRNB3—brainstem—malignant glioma	0.00331	0.0229	CbGeAlD
Nicotine—CHRNB3—telencephalon—malignant glioma	0.00294	0.0203	CbGeAlD
Nicotine—CHRNA6—brainstem—malignant glioma	0.00276	0.0191	CbGeAlD
Nicotine—CHRNA6—telencephalon—malignant glioma	0.00245	0.0169	CbGeAlD
Nicotine—CHAT—brainstem—malignant glioma	0.00229	0.0159	CbGeAlD
Nicotine—Cerebration impaired—Temozolomide—malignant glioma	0.00223	0.0254	CcSEcCtD
Nicotine—CHAT—retina—malignant glioma	0.00221	0.0153	CbGeAlD
Nicotine—CHRNB3—midbrain—malignant glioma	0.00211	0.0146	CbGeAlD
Nicotine—Aphasia—Carmustine—malignant glioma	0.00209	0.0238	CcSEcCtD
Nicotine—CHAT—telencephalon—malignant glioma	0.00203	0.0141	CbGeAlD
Nicotine—Aphasia—Temozolomide—malignant glioma	0.00202	0.023	CcSEcCtD
Nicotine—Tooth disorder—Temozolomide—malignant glioma	0.00202	0.023	CcSEcCtD
Nicotine—Burning sensation—Carmustine—malignant glioma	0.00195	0.0222	CcSEcCtD
Nicotine—CHRNA5—central nervous system—malignant glioma	0.00184	0.0127	CbGeAlD
Nicotine—Influenza-like symptoms—Temozolomide—malignant glioma	0.00183	0.0209	CcSEcCtD
Nicotine—Apathy—Temozolomide—malignant glioma	0.00183	0.0209	CcSEcCtD
Nicotine—Flat affect—Temozolomide—malignant glioma	0.00182	0.0207	CcSEcCtD
Nicotine—CHRNA6—midbrain—malignant glioma	0.00176	0.0122	CbGeAlD
Nicotine—CHRNB3—central nervous system—malignant glioma	0.00167	0.0115	CbGeAlD
Nicotine—Memory impairment—Temozolomide—malignant glioma	0.00167	0.019	CcSEcCtD
Nicotine—CHRNB3—cerebellum—malignant glioma	0.00163	0.0113	CbGeAlD
Nicotine—CHAT—medulla oblongata—malignant glioma	0.0016	0.0111	CbGeAlD
Nicotine—Disturbance in attention—Temozolomide—malignant glioma	0.00151	0.0172	CcSEcCtD
Nicotine—CHRNA3—retina—malignant glioma	0.00148	0.0103	CbGeAlD
Nicotine—CHAT—midbrain—malignant glioma	0.00146	0.0101	CbGeAlD
Nicotine—CHRNA5—brain—malignant glioma	0.00146	0.0101	CbGeAlD
Nicotine—CHAT—spinal cord—malignant glioma	0.00143	0.00986	CbGeAlD
Nicotine—CHRNB2—telencephalon—malignant glioma	0.00141	0.00973	CbGeAlD
Nicotine—CHRNA6—central nervous system—malignant glioma	0.00139	0.00963	CbGeAlD
Nicotine—Coordination abnormal—Carmustine—malignant glioma	0.00138	0.0157	CcSEcCtD
Nicotine—CHRNA6—cerebellum—malignant glioma	0.00136	0.00941	CbGeAlD
Nicotine—Coordination abnormal—Temozolomide—malignant glioma	0.00133	0.0152	CcSEcCtD
Nicotine—Respiratory failure—Temozolomide—malignant glioma	0.00133	0.0152	CcSEcCtD
Nicotine—CHRNB3—brain—malignant glioma	0.00132	0.00916	CbGeAlD
Nicotine—Influenza like illness—Temozolomide—malignant glioma	0.00127	0.0145	CcSEcCtD
Nicotine—CHRNB4—central nervous system—malignant glioma	0.00126	0.00874	CbGeAlD
Nicotine—Abnormal vision—Carmustine—malignant glioma	0.00118	0.0135	CcSEcCtD
Nicotine—Mental disability—Carmustine—malignant glioma	0.00118	0.0134	CcSEcCtD
Nicotine—CHAT—central nervous system—malignant glioma	0.00116	0.008	CbGeAlD
Nicotine—Abnormal vision—Temozolomide—malignant glioma	0.00114	0.013	CcSEcCtD
Nicotine—Mental disability—Temozolomide—malignant glioma	0.00114	0.013	CcSEcCtD
Nicotine—CHAT—cerebellum—malignant glioma	0.00113	0.00782	CbGeAlD
Nicotine—Ear pain—Temozolomide—malignant glioma	0.00111	0.0127	CcSEcCtD
Nicotine—CHRNB2—medulla oblongata—malignant glioma	0.00111	0.00764	CbGeAlD
Nicotine—CHRNA6—brain—malignant glioma	0.00111	0.00764	CbGeAlD
Nicotine—CHRFAM7A—telencephalon—malignant glioma	0.0011	0.00763	CbGeAlD
Nicotine—Amnesia—Carmustine—malignant glioma	0.00105	0.0119	CcSEcCtD
Nicotine—Nasal congestion—Temozolomide—malignant glioma	0.00104	0.0119	CcSEcCtD
Nicotine—Hot flush—Temozolomide—malignant glioma	0.00102	0.0116	CcSEcCtD
Nicotine—Amnesia—Temozolomide—malignant glioma	0.00101	0.0115	CcSEcCtD
Nicotine—CHRNB2—midbrain—malignant glioma	0.00101	0.00699	CbGeAlD
Nicotine—Menopausal symptoms—Temozolomide—malignant glioma	0.00101	0.0115	CcSEcCtD
Nicotine—CHRNB4—brain—malignant glioma	0.001	0.00694	CbGeAlD
Nicotine—CHRNA4—brainstem—malignant glioma	0.000991	0.00685	CbGeAlD
Nicotine—CHRNB2—spinal cord—malignant glioma	0.000986	0.00682	CbGeAlD
Nicotine—CHRNA7—retina—malignant glioma	0.000969	0.0067	CbGeAlD
Nicotine—Affect lability—Temozolomide—malignant glioma	0.000936	0.0107	CcSEcCtD
Nicotine—CHAT—brain—malignant glioma	0.000918	0.00635	CbGeAlD
Nicotine—Mood swings—Temozolomide—malignant glioma	0.000901	0.0103	CcSEcCtD
Nicotine—CHRNA7—telencephalon—malignant glioma	0.000891	0.00616	CbGeAlD
Nicotine—CHRNA4—telencephalon—malignant glioma	0.000879	0.00608	CbGeAlD
Nicotine—SLC22A3—embryo—malignant glioma	0.000874	0.00604	CbGeAlD
Nicotine—Dysphagia—Carmustine—malignant glioma	0.00085	0.00969	CcSEcCtD
Nicotine—Dysphagia—Temozolomide—malignant glioma	0.000822	0.00936	CcSEcCtD
Nicotine—MAOB—embryo—malignant glioma	0.000808	0.00559	CbGeAlD
Nicotine—Sweating increased—Temozolomide—malignant glioma	0.0008	0.00912	CcSEcCtD
Nicotine—CHRNB2—central nervous system—malignant glioma	0.0008	0.00553	CbGeAlD
Nicotine—Bronchitis—Temozolomide—malignant glioma	0.00079	0.00901	CcSEcCtD
Nicotine—CHRNB2—cerebellum—malignant glioma	0.000782	0.00541	CbGeAlD
Nicotine—CHRNA3—central nervous system—malignant glioma	0.000776	0.00536	CbGeAlD
Nicotine—CHRNA3—cerebellum—malignant glioma	0.000758	0.00524	CbGeAlD
Nicotine—Weight increased—Temozolomide—malignant glioma	0.000748	0.00852	CcSEcCtD
Nicotine—SLC22A1—telencephalon—malignant glioma	0.000743	0.00514	CbGeAlD
Nicotine—MAOB—brainstem—malignant glioma	0.000741	0.00512	CbGeAlD
Nicotine—Stomatitis—Carmustine—malignant glioma	0.000739	0.00842	CcSEcCtD
Nicotine—CHRNA2—central nervous system—malignant glioma	0.000721	0.00499	CbGeAlD
Nicotine—Stomatitis—Temozolomide—malignant glioma	0.000714	0.00814	CcSEcCtD
Nicotine—CHRNA2—cerebellum—malignant glioma	0.000705	0.00487	CbGeAlD
Nicotine—MAOA—embryo—malignant glioma	0.00069	0.00477	CbGeAlD
Nicotine—Sinusitis—Temozolomide—malignant glioma	0.000687	0.00783	CcSEcCtD
Nicotine—Hypoaesthesia—Carmustine—malignant glioma	0.000677	0.00772	CcSEcCtD
Nicotine—Oedema peripheral—Carmustine—malignant glioma	0.00067	0.00764	CcSEcCtD
Nicotine—MAOB—telencephalon—malignant glioma	0.000657	0.00455	CbGeAlD
Nicotine—Visual impairment—Carmustine—malignant glioma	0.000656	0.00747	CcSEcCtD
Nicotine—Hypoaesthesia—Temozolomide—malignant glioma	0.000654	0.00746	CcSEcCtD
Nicotine—Pharyngitis—Temozolomide—malignant glioma	0.000653	0.00744	CcSEcCtD
Nicotine—Oedema peripheral—Temozolomide—malignant glioma	0.000648	0.00738	CcSEcCtD
Nicotine—CHRNB2—brain—malignant glioma	0.000635	0.00439	CbGeAlD
Nicotine—Visual impairment—Temozolomide—malignant glioma	0.000634	0.00722	CcSEcCtD
Nicotine—MAOA—brainstem—malignant glioma	0.000632	0.00437	CbGeAlD
Nicotine—Flushing—Carmustine—malignant glioma	0.000632	0.0072	CcSEcCtD
Nicotine—CHRNA4—midbrain—malignant glioma	0.000632	0.00437	CbGeAlD
Nicotine—CHRFAM7A—central nervous system—malignant glioma	0.000627	0.00434	CbGeAlD
Nicotine—CHRNA4—spinal cord—malignant glioma	0.000616	0.00426	CbGeAlD
Nicotine—CHRNA3—brain—malignant glioma	0.000616	0.00426	CbGeAlD
Nicotine—Flushing—Temozolomide—malignant glioma	0.00061	0.00696	CcSEcCtD
Nicotine—Cardiac disorder—Temozolomide—malignant glioma	0.00061	0.00696	CcSEcCtD
Nicotine—MAOA—retina—malignant glioma	0.00061	0.00422	CbGeAlD
Nicotine—Arrhythmia—Carmustine—malignant glioma	0.000608	0.00693	CcSEcCtD
Nicotine—Mental disorder—Carmustine—malignant glioma	0.000596	0.00679	CcSEcCtD
Nicotine—Immune system disorder—Temozolomide—malignant glioma	0.000594	0.00677	CcSEcCtD
Nicotine—Mediastinal disorder—Temozolomide—malignant glioma	0.000593	0.00675	CcSEcCtD
Nicotine—Erythema—Carmustine—malignant glioma	0.000592	0.00675	CcSEcCtD
Nicotine—Mental disorder—Temozolomide—malignant glioma	0.000576	0.00657	CcSEcCtD
Nicotine—Back pain—Carmustine—malignant glioma	0.000573	0.00653	CcSEcCtD
Nicotine—CHRNA2—brain—malignant glioma	0.000573	0.00396	CbGeAlD
Nicotine—Erythema—Temozolomide—malignant glioma	0.000573	0.00652	CcSEcCtD
Nicotine—SLC22A5—retina—malignant glioma	0.000562	0.00388	CbGeAlD
Nicotine—MAOA—telencephalon—malignant glioma	0.000561	0.00388	CbGeAlD
Nicotine—Dysgeusia—Temozolomide—malignant glioma	0.000561	0.00639	CcSEcCtD
Nicotine—Tremor—Carmustine—malignant glioma	0.000555	0.00633	CcSEcCtD
Nicotine—Back pain—Temozolomide—malignant glioma	0.000554	0.00631	CcSEcCtD
Nicotine—SLC22A4—spinal cord—malignant glioma	0.000547	0.00378	CbGeAlD
Nicotine—Agitation—Carmustine—malignant glioma	0.000544	0.0062	CcSEcCtD
Nicotine—Tremor—Temozolomide—malignant glioma	0.000536	0.00611	CcSEcCtD
Nicotine—Ill-defined disorder—Temozolomide—malignant glioma	0.000531	0.00605	CcSEcCtD
Nicotine—Agitation—Temozolomide—malignant glioma	0.000526	0.006	CcSEcCtD
Nicotine—Angioedema—Temozolomide—malignant glioma	0.000523	0.00596	CcSEcCtD
Nicotine—MAOB—medulla oblongata—malignant glioma	0.000517	0.00357	CbGeAlD
Nicotine—Malaise—Temozolomide—malignant glioma	0.000516	0.00588	CcSEcCtD
Nicotine—Vertigo—Temozolomide—malignant glioma	0.000514	0.00586	CcSEcCtD
Nicotine—Convulsion—Carmustine—malignant glioma	0.000513	0.00585	CcSEcCtD
Nicotine—Hypertension—Carmustine—malignant glioma	0.000511	0.00583	CcSEcCtD
Nicotine—CHRNA7—central nervous system—malignant glioma	0.000507	0.0035	CbGeAlD
Nicotine—Palpitations—Temozolomide—malignant glioma	0.000506	0.00577	CcSEcCtD
Nicotine—Myalgia—Carmustine—malignant glioma	0.000504	0.00575	CcSEcCtD
Nicotine—Chest pain—Carmustine—malignant glioma	0.000504	0.00575	CcSEcCtD
Nicotine—Anxiety—Carmustine—malignant glioma	0.000503	0.00573	CcSEcCtD
Nicotine—CHRNA4—central nervous system—malignant glioma	0.0005	0.00346	CbGeAlD
Nicotine—Cough—Temozolomide—malignant glioma	0.0005	0.00569	CcSEcCtD
Nicotine—CHRFAM7A—brain—malignant glioma	0.000498	0.00344	CbGeAlD
Nicotine—Convulsion—Temozolomide—malignant glioma	0.000496	0.00565	CcSEcCtD
Nicotine—CYP2A6—cerebellum—malignant glioma	0.000495	0.00342	CbGeAlD
Nicotine—Hypertension—Temozolomide—malignant glioma	0.000494	0.00563	CcSEcCtD
Nicotine—CHRNA4—cerebellum—malignant glioma	0.000489	0.00338	CbGeAlD
Nicotine—Confusional state—Carmustine—malignant glioma	0.000488	0.00556	CcSEcCtD
Nicotine—Arthralgia—Temozolomide—malignant glioma	0.000487	0.00555	CcSEcCtD
Nicotine—Myalgia—Temozolomide—malignant glioma	0.000487	0.00555	CcSEcCtD
Nicotine—Anxiety—Temozolomide—malignant glioma	0.000486	0.00554	CcSEcCtD
Nicotine—Oedema—Carmustine—malignant glioma	0.000484	0.00551	CcSEcCtD
Nicotine—Discomfort—Temozolomide—malignant glioma	0.000482	0.00549	CcSEcCtD
Nicotine—Dry mouth—Temozolomide—malignant glioma	0.000477	0.00543	CcSEcCtD
Nicotine—MAOB—midbrain—malignant glioma	0.000472	0.00326	CbGeAlD
Nicotine—Tachycardia—Carmustine—malignant glioma	0.000472	0.00538	CcSEcCtD
Nicotine—Confusional state—Temozolomide—malignant glioma	0.000471	0.00537	CcSEcCtD
Nicotine—Anaphylactic shock—Temozolomide—malignant glioma	0.000467	0.00532	CcSEcCtD
Nicotine—Oedema—Temozolomide—malignant glioma	0.000467	0.00532	CcSEcCtD
Nicotine—MAOB—spinal cord—malignant glioma	0.000461	0.00318	CbGeAlD
Nicotine—Nervous system disorder—Temozolomide—malignant glioma	0.000458	0.00522	CcSEcCtD
Nicotine—Hypotension—Carmustine—malignant glioma	0.000452	0.00515	CcSEcCtD
Nicotine—Hyperhidrosis—Temozolomide—malignant glioma	0.000452	0.00515	CcSEcCtD
Nicotine—MAOA—medulla oblongata—malignant glioma	0.000441	0.00305	CbGeAlD
Nicotine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000441	0.00502	CcSEcCtD
Nicotine—Insomnia—Carmustine—malignant glioma	0.000437	0.00498	CcSEcCtD
Nicotine—Paraesthesia—Carmustine—malignant glioma	0.000434	0.00495	CcSEcCtD
Nicotine—SLC22A4—cerebellum—malignant glioma	0.000434	0.003	CbGeAlD
Nicotine—Dyspnoea—Carmustine—malignant glioma	0.000431	0.00491	CcSEcCtD
Nicotine—Somnolence—Carmustine—malignant glioma	0.00043	0.0049	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000426	0.00485	CcSEcCtD
Nicotine—Insomnia—Temozolomide—malignant glioma	0.000423	0.00482	CcSEcCtD
Nicotine—SLC22A1—central nervous system—malignant glioma	0.000422	0.00292	CbGeAlD
Nicotine—CYP2E1—telencephalon—malignant glioma	0.000421	0.00291	CbGeAlD
Nicotine—Paraesthesia—Temozolomide—malignant glioma	0.00042	0.00478	CcSEcCtD
Nicotine—Gastrointestinal disorder—Carmustine—malignant glioma	0.000417	0.00476	CcSEcCtD
Nicotine—Dyspnoea—Temozolomide—malignant glioma	0.000417	0.00475	CcSEcCtD
Nicotine—Somnolence—Temozolomide—malignant glioma	0.000415	0.00473	CcSEcCtD
Nicotine—Constipation—Carmustine—malignant glioma	0.000413	0.00471	CcSEcCtD
Nicotine—Pain—Carmustine—malignant glioma	0.000413	0.00471	CcSEcCtD
Nicotine—Dyspepsia—Temozolomide—malignant glioma	0.000411	0.00469	CcSEcCtD
Nicotine—SLC22A5—medulla oblongata—malignant glioma	0.000406	0.00281	CbGeAlD
Nicotine—SLC22A3—central nervous system—malignant glioma	0.000404	0.00279	CbGeAlD
Nicotine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000403	0.0046	CcSEcCtD
Nicotine—Fatigue—Temozolomide—malignant glioma	0.000403	0.00459	CcSEcCtD
Nicotine—MAOA—midbrain—malignant glioma	0.000403	0.00278	CbGeAlD
Nicotine—CHRNA7—brain—malignant glioma	0.000402	0.00278	CbGeAlD
Nicotine—CYP2A6—brain—malignant glioma	0.000402	0.00278	CbGeAlD
Nicotine—Pain—Temozolomide—malignant glioma	0.0004	0.00455	CcSEcCtD
Nicotine—Constipation—Temozolomide—malignant glioma	0.0004	0.00455	CcSEcCtD
Nicotine—Feeling abnormal—Carmustine—malignant glioma	0.000398	0.00454	CcSEcCtD
Nicotine—CYP19A1—central nervous system—malignant glioma	0.000397	0.00274	CbGeAlD
Nicotine—CHRNA4—brain—malignant glioma	0.000397	0.00274	CbGeAlD
Nicotine—Gastrointestinal pain—Carmustine—malignant glioma	0.000395	0.00451	CcSEcCtD
Nicotine—MAOA—spinal cord—malignant glioma	0.000393	0.00272	CbGeAlD
Nicotine—Feeling abnormal—Temozolomide—malignant glioma	0.000385	0.00439	CcSEcCtD
Nicotine—Body temperature increased—Carmustine—malignant glioma	0.000382	0.00436	CcSEcCtD
Nicotine—Abdominal pain—Carmustine—malignant glioma	0.000382	0.00436	CcSEcCtD
Nicotine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000382	0.00435	CcSEcCtD
Nicotine—CYP2D6—brainstem—malignant glioma	0.000376	0.0026	CbGeAlD
Nicotine—MAOB—central nervous system—malignant glioma	0.000374	0.00258	CbGeAlD
Nicotine—Urticaria—Temozolomide—malignant glioma	0.000371	0.00423	CcSEcCtD
Nicotine—SLC22A5—midbrain—malignant glioma	0.000371	0.00256	CbGeAlD
Nicotine—Body temperature increased—Temozolomide—malignant glioma	0.000369	0.00421	CcSEcCtD
Nicotine—Abdominal pain—Temozolomide—malignant glioma	0.000369	0.00421	CcSEcCtD
Nicotine—MAOB—cerebellum—malignant glioma	0.000365	0.00253	CbGeAlD
Nicotine—SLC22A5—spinal cord—malignant glioma	0.000362	0.0025	CbGeAlD
Nicotine—Hypersensitivity—Carmustine—malignant glioma	0.000356	0.00406	CcSEcCtD
Nicotine—SLC22A4—brain—malignant glioma	0.000352	0.00244	CbGeAlD
Nicotine—Asthenia—Carmustine—malignant glioma	0.000347	0.00395	CcSEcCtD
Nicotine—Hypersensitivity—Temozolomide—malignant glioma	0.000344	0.00392	CcSEcCtD
Nicotine—SLC22A1—brain—malignant glioma	0.000335	0.00232	CbGeAlD
Nicotine—Asthenia—Temozolomide—malignant glioma	0.000335	0.00382	CcSEcCtD
Nicotine—CYP2D6—telencephalon—malignant glioma	0.000333	0.0023	CbGeAlD
Nicotine—Diarrhoea—Carmustine—malignant glioma	0.000331	0.00377	CcSEcCtD
Nicotine—CYP2E1—medulla oblongata—malignant glioma	0.000331	0.00229	CbGeAlD
Nicotine—Pruritus—Temozolomide—malignant glioma	0.000331	0.00377	CcSEcCtD
Nicotine—SLC22A3—brain—malignant glioma	0.000321	0.00222	CbGeAlD
Nicotine—Dizziness—Carmustine—malignant glioma	0.00032	0.00364	CcSEcCtD
Nicotine—Diarrhoea—Temozolomide—malignant glioma	0.00032	0.00364	CcSEcCtD
Nicotine—MAOA—central nervous system—malignant glioma	0.000319	0.0022	CbGeAlD
Nicotine—CYP19A1—brain—malignant glioma	0.000315	0.00218	CbGeAlD
Nicotine—MAOA—cerebellum—malignant glioma	0.000312	0.00215	CbGeAlD
Nicotine—Dizziness—Temozolomide—malignant glioma	0.000309	0.00352	CcSEcCtD
Nicotine—Vomiting—Carmustine—malignant glioma	0.000307	0.0035	CcSEcCtD
Nicotine—Rash—Carmustine—malignant glioma	0.000305	0.00347	CcSEcCtD
Nicotine—Dermatitis—Carmustine—malignant glioma	0.000305	0.00347	CcSEcCtD
Nicotine—Headache—Carmustine—malignant glioma	0.000303	0.00345	CcSEcCtD
Nicotine—Vomiting—Temozolomide—malignant glioma	0.000297	0.00339	CcSEcCtD
Nicotine—MAOB—brain—malignant glioma	0.000297	0.00205	CbGeAlD
Nicotine—CYP2E1—spinal cord—malignant glioma	0.000295	0.00204	CbGeAlD
Nicotine—Rash—Temozolomide—malignant glioma	0.000295	0.00336	CcSEcCtD
Nicotine—Dermatitis—Temozolomide—malignant glioma	0.000294	0.00335	CcSEcCtD
Nicotine—Headache—Temozolomide—malignant glioma	0.000293	0.00334	CcSEcCtD
Nicotine—Nausea—Carmustine—malignant glioma	0.000287	0.00327	CcSEcCtD
Nicotine—SLC22A5—cerebellum—malignant glioma	0.000287	0.00198	CbGeAlD
Nicotine—Nausea—Temozolomide—malignant glioma	0.000278	0.00316	CcSEcCtD
Nicotine—CYP1A1—central nervous system—malignant glioma	0.000262	0.00181	CbGeAlD
Nicotine—CYP2B6—central nervous system—malignant glioma	0.000255	0.00176	CbGeAlD
Nicotine—MAOA—brain—malignant glioma	0.000253	0.00175	CbGeAlD
Nicotine—CYP2E1—central nervous system—malignant glioma	0.000239	0.00165	CbGeAlD
Nicotine—CYP2E1—cerebellum—malignant glioma	0.000234	0.00162	CbGeAlD
Nicotine—SLC22A5—brain—malignant glioma	0.000233	0.00161	CbGeAlD
Nicotine—CYP2C8—brain—malignant glioma	0.000226	0.00156	CbGeAlD
Nicotine—CYP1A1—brain—malignant glioma	0.000208	0.00144	CbGeAlD
Nicotine—CYP2B6—brain—malignant glioma	0.000202	0.0014	CbGeAlD
Nicotine—CYP3A4—central nervous system—malignant glioma	0.000193	0.00133	CbGeAlD
Nicotine—CYP2E1—brain—malignant glioma	0.00019	0.00131	CbGeAlD
Nicotine—CYP2D6—central nervous system—malignant glioma	0.000189	0.00131	CbGeAlD
Nicotine—CYP2D6—cerebellum—malignant glioma	0.000185	0.00128	CbGeAlD
Nicotine—CYP2D6—brain—malignant glioma	0.00015	0.00104	CbGeAlD
Nicotine—CYP2D6—Metabolism—SPHK1—malignant glioma	1.02e-05	5.88e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—GSTP1—malignant glioma	1.01e-05	5.85e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—BCHE—malignant glioma	1.01e-05	5.84e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—SPHK1—malignant glioma	1.01e-05	5.83e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.01e-05	5.82e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PTGS1—malignant glioma	1e-05	5.8e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1e-05	5.78e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—SLC5A5—malignant glioma	9.99e-06	5.77e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—NCOR1—malignant glioma	9.99e-06	5.77e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CYP2C18—malignant glioma	9.98e-06	5.76e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—GSTP1—malignant glioma	9.98e-06	5.76e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—BCAN—malignant glioma	9.93e-06	5.74e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—BCHE—malignant glioma	9.91e-06	5.72e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CYP2C18—malignant glioma	9.89e-06	5.71e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CAT—malignant glioma	9.86e-06	5.69e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GSTT1—malignant glioma	9.83e-06	5.68e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—SLC5A5—malignant glioma	9.79e-06	5.65e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	9.78e-06	5.65e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP2B6—malignant glioma	9.75e-06	5.63e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CAT—malignant glioma	9.71e-06	5.61e-05	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—AKT1—malignant glioma	9.68e-06	5.59e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—CAV1—malignant glioma	9.63e-06	5.56e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—CAV1—malignant glioma	9.39e-06	5.42e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—BCHE—malignant glioma	9.34e-06	5.4e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	9.33e-06	5.39e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	9.32e-06	5.38e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—NCOR1—malignant glioma	9.31e-06	5.38e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PTEN—malignant glioma	9.25e-06	5.34e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—SLC5A5—malignant glioma	9.23e-06	5.33e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PTGS1—malignant glioma	9.21e-06	5.32e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.18e-06	5.3e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—NCOR1—malignant glioma	9.17e-06	5.3e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PIK3CB—malignant glioma	9.06e-06	5.23e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.99e-06	5.2e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PTGS2—malignant glioma	8.98e-06	5.18e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.97e-06	5.18e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—IDH1—malignant glioma	8.92e-06	5.15e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GSTT1—malignant glioma	8.77e-06	5.07e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PIK3CG—malignant glioma	8.77e-06	5.06e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.73e-06	5.04e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.65e-06	4.99e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—SPHK1—malignant glioma	8.63e-06	4.98e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—BCHE—malignant glioma	8.56e-06	4.95e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PIK3CG—malignant glioma	8.55e-06	4.94e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	8.5e-06	4.91e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PPARG—malignant glioma	8.46e-06	4.89e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—SLC5A5—malignant glioma	8.46e-06	4.89e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP2C18—malignant glioma	8.45e-06	4.88e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PPARG—malignant glioma	8.25e-06	4.77e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PTGS1—malignant glioma	8.22e-06	4.75e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.2e-06	4.74e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.19e-06	4.73e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CAV1—malignant glioma	8.14e-06	4.7e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GSTT1—malignant glioma	8.07e-06	4.66e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—GSTP1—malignant glioma	8.05e-06	4.65e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—IDH2—malignant glioma	8e-06	4.62e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GSTT1—malignant glioma	8e-06	4.62e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8e-06	4.62e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	7.97e-06	4.6e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.93e-06	4.58e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GSTP1—malignant glioma	7.88e-06	4.55e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CAT—malignant glioma	7.83e-06	4.52e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PTEN—malignant glioma	7.83e-06	4.52e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PIK3CD—malignant glioma	7.71e-06	4.45e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CAT—malignant glioma	7.67e-06	4.43e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—BCHE—malignant glioma	7.64e-06	4.42e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CAV1—malignant glioma	7.59e-06	4.38e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PTGS1—malignant glioma	7.56e-06	4.37e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—SLC5A5—malignant glioma	7.55e-06	4.36e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.54e-06	4.36e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP2B6—malignant glioma	7.53e-06	4.35e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PIK3CD—malignant glioma	7.52e-06	4.34e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PTGS1—malignant glioma	7.5e-06	4.33e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CAV1—malignant glioma	7.47e-06	4.32e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.47e-06	4.31e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GSTP1—malignant glioma	7.43e-06	4.29e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PIK3CG—malignant glioma	7.42e-06	4.28e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—NCOR1—malignant glioma	7.4e-06	4.27e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.26e-06	4.19e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—NCOR1—malignant glioma	7.24e-06	4.18e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CAT—malignant glioma	7.23e-06	4.18e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PPARG—malignant glioma	7.16e-06	4.13e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.14e-06	4.12e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.08e-06	4.09e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—BCHE—malignant glioma	7.03e-06	4.06e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.01e-06	4.05e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—BCHE—malignant glioma	6.97e-06	4.03e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—SLC5A5—malignant glioma	6.94e-06	4.01e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.91e-06	3.99e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PIK3CG—malignant glioma	6.91e-06	3.99e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—SLC5A5—malignant glioma	6.88e-06	3.98e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—IDH1—malignant glioma	6.88e-06	3.98e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GSTT1—malignant glioma	6.84e-06	3.95e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—NCOR1—malignant glioma	6.83e-06	3.95e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GSTP1—malignant glioma	6.81e-06	3.94e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PIK3CG—malignant glioma	6.81e-06	3.93e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PIK3CB—malignant glioma	6.72e-06	3.88e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PPARG—malignant glioma	6.67e-06	3.85e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—SPHK1—malignant glioma	6.66e-06	3.85e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PTGS2—malignant glioma	6.66e-06	3.85e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CAT—malignant glioma	6.63e-06	3.83e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PPARG—malignant glioma	6.57e-06	3.79e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PIK3CB—malignant glioma	6.55e-06	3.79e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PIK3CA—malignant glioma	6.53e-06	3.77e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP2C18—malignant glioma	6.52e-06	3.77e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PIK3CD—malignant glioma	6.52e-06	3.77e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.51e-06	3.76e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PTGS2—malignant glioma	6.49e-06	3.75e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.45e-06	3.73e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PTGS1—malignant glioma	6.41e-06	3.7e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.38e-06	3.69e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—NCOR1—malignant glioma	6.26e-06	3.62e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.17e-06	3.56e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GSTP1—malignant glioma	6.08e-06	3.51e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PIK3CD—malignant glioma	6.08e-06	3.51e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CAV1—malignant glioma	6.03e-06	3.48e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PIK3CD—malignant glioma	5.98e-06	3.46e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—BCHE—malignant glioma	5.96e-06	3.44e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CAT—malignant glioma	5.92e-06	3.42e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CAV1—malignant glioma	5.91e-06	3.41e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—SLC5A5—malignant glioma	5.88e-06	3.4e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PTEN—malignant glioma	5.81e-06	3.35e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PIK3CB—malignant glioma	5.68e-06	3.28e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PTEN—malignant glioma	5.66e-06	3.27e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PTGS2—malignant glioma	5.63e-06	3.25e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.63e-06	3.25e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GSTP1—malignant glioma	5.59e-06	3.23e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—NCOR1—malignant glioma	5.59e-06	3.23e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CAV1—malignant glioma	5.57e-06	3.22e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.56e-06	3.21e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GSTP1—malignant glioma	5.55e-06	3.2e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PIK3CA—malignant glioma	5.52e-06	3.19e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.51e-06	3.18e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PIK3CG—malignant glioma	5.49e-06	3.17e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CAT—malignant glioma	5.44e-06	3.14e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CAT—malignant glioma	5.4e-06	3.12e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PIK3CG—malignant glioma	5.38e-06	3.11e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—AKT1—malignant glioma	5.33e-06	3.08e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.32e-06	3.07e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PPARG—malignant glioma	5.3e-06	3.06e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PIK3CB—malignant glioma	5.3e-06	3.06e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTT1—malignant glioma	5.28e-06	3.05e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PTGS2—malignant glioma	5.25e-06	3.03e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PIK3CB—malignant glioma	5.22e-06	3.01e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PPARG—malignant glioma	5.19e-06	3e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PTGS2—malignant glioma	5.17e-06	2.99e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—NCOR1—malignant glioma	5.14e-06	2.97e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CAV1—malignant glioma	5.1e-06	2.95e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—NCOR1—malignant glioma	5.1e-06	2.94e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PIK3CG—malignant glioma	5.07e-06	2.93e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PTGS1—malignant glioma	4.94e-06	2.86e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PTEN—malignant glioma	4.91e-06	2.84e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PPARG—malignant glioma	4.89e-06	2.83e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.88e-06	2.82e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PIK3CD—malignant glioma	4.83e-06	2.79e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.81e-06	2.78e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GSTP1—malignant glioma	4.74e-06	2.74e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PIK3CD—malignant glioma	4.73e-06	2.73e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PIK3CG—malignant glioma	4.65e-06	2.69e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CAT—malignant glioma	4.61e-06	2.66e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—BCHE—malignant glioma	4.6e-06	2.66e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PTEN—malignant glioma	4.58e-06	2.64e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CAV1—malignant glioma	4.56e-06	2.63e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.54e-06	2.62e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—AKT1—malignant glioma	4.51e-06	2.61e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PTEN—malignant glioma	4.51e-06	2.6e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PPARG—malignant glioma	4.49e-06	2.59e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PIK3CD—malignant glioma	4.46e-06	2.58e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—NCOR1—malignant glioma	4.36e-06	2.52e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.35e-06	2.51e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PIK3CB—malignant glioma	4.21e-06	2.43e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CAV1—malignant glioma	4.19e-06	2.42e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PTGS2—malignant glioma	4.17e-06	2.41e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CAV1—malignant glioma	4.15e-06	2.4e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PIK3CG—malignant glioma	4.15e-06	2.4e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PIK3CB—malignant glioma	4.12e-06	2.38e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PIK3CA—malignant glioma	4.1e-06	2.37e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PIK3CD—malignant glioma	4.09e-06	2.36e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PTGS2—malignant glioma	4.08e-06	2.36e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PPARG—malignant glioma	4.01e-06	2.31e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PIK3CA—malignant glioma	3.99e-06	2.31e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.97e-06	2.29e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PIK3CB—malignant glioma	3.89e-06	2.24e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PTGS2—malignant glioma	3.85e-06	2.22e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.82e-06	2.2e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PIK3CG—malignant glioma	3.78e-06	2.19e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PPARG—malignant glioma	3.68e-06	2.13e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTP1—malignant glioma	3.66e-06	2.11e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PPARG—malignant glioma	3.65e-06	2.11e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PIK3CD—malignant glioma	3.65e-06	2.11e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PTEN—malignant glioma	3.64e-06	2.1e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PIK3CB—malignant glioma	3.56e-06	2.06e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PTEN—malignant glioma	3.56e-06	2.06e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CAT—malignant glioma	3.56e-06	2.06e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CAV1—malignant glioma	3.55e-06	2.05e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PTGS2—malignant glioma	3.53e-06	2.04e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PIK3CA—malignant glioma	3.46e-06	2e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.39e-06	1.96e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NCOR1—malignant glioma	3.36e-06	1.94e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PTEN—malignant glioma	3.36e-06	1.94e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.36e-06	1.94e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—AKT1—malignant glioma	3.35e-06	1.93e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PIK3CD—malignant glioma	3.33e-06	1.92e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—AKT1—malignant glioma	3.26e-06	1.88e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PIK3CG—malignant glioma	3.23e-06	1.87e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PIK3CA—malignant glioma	3.23e-06	1.86e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PIK3CB—malignant glioma	3.18e-06	1.84e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PIK3CA—malignant glioma	3.18e-06	1.84e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PTGS2—malignant glioma	3.15e-06	1.82e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PPARG—malignant glioma	3.12e-06	1.8e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PTEN—malignant glioma	3.08e-06	1.78e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.92e-06	1.69e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.9e-06	1.67e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PTGS2—malignant glioma	2.9e-06	1.67e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PTGS2—malignant glioma	2.87e-06	1.66e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.84e-06	1.64e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—AKT1—malignant glioma	2.83e-06	1.63e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PTEN—malignant glioma	2.75e-06	1.59e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CAV1—malignant glioma	2.74e-06	1.58e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—AKT1—malignant glioma	2.64e-06	1.52e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—AKT1—malignant glioma	2.6e-06	1.5e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PIK3CA—malignant glioma	2.57e-06	1.48e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PTEN—malignant glioma	2.53e-06	1.46e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PIK3CA—malignant glioma	2.51e-06	1.45e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PTEN—malignant glioma	2.51e-06	1.45e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.5e-06	1.44e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PIK3CB—malignant glioma	2.48e-06	1.43e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PTGS2—malignant glioma	2.46e-06	1.42e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PPARG—malignant glioma	2.41e-06	1.39e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PIK3CA—malignant glioma	2.37e-06	1.37e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.19e-06	1.27e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PIK3CA—malignant glioma	2.17e-06	1.25e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PTEN—malignant glioma	2.14e-06	1.24e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—AKT1—malignant glioma	2.1e-06	1.21e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—AKT1—malignant glioma	2.05e-06	1.19e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.94e-06	1.12e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—AKT1—malignant glioma	1.94e-06	1.12e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.91e-06	1.1e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.89e-06	1.09e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.78e-06	1.03e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—AKT1—malignant glioma	1.77e-06	1.02e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.77e-06	1.02e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PTEN—malignant glioma	1.65e-06	9.55e-06	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—AKT1—malignant glioma	1.58e-06	9.15e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.51e-06	8.73e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—AKT1—malignant glioma	1.46e-06	8.41e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—AKT1—malignant glioma	1.44e-06	8.34e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—AKT1—malignant glioma	1.23e-06	7.13e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.17e-06	6.73e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—AKT1—malignant glioma	9.52e-07	5.5e-06	CbGpPWpGaD
